Lisata Therapeutics, Inc. Common Stock (NASDAQ: LSTA) last traded at $1.55, up 38.39% on the session. The quote above updates while this page is open; the figures below are drawn from Lisata Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Lisata Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker LSTA. Its market capitalisation is $13.97 million.
Valuation measures for Lisata Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $13.97M |
|---|---|
| Enterprise value | $6.56M |
| Price / sales | 139.67 |
| Price / book | 1.69 |
| Beta | 0.75 |
Trailing-twelve-month figures tagged in Lisata Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $100.0K |
|---|---|
| Net income (TTM) | -$14.62M |
| EPS (TTM) | -$1.64 |
| Operating margin | -16428.00% |
| Return on equity | -177.35% |
| Cash | $10.44M |
Range and volume for LSTA over the past 52 weeks.
| 52-week high | $5.07 |
|---|---|
| 52-week low | $0.990 |
| Volume | 7.03M |
| Average volume | 241.4K |
| Previous close | $1.12 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.